$3.14
-0.03[-0.95%]
At close: Apr 25
$3.14
0[0.00%]
PreMarket: 6:42AM EDT
Abeona Therapeutics
(NASDAQ:ABEO)Latest News for Abeona Therapeutics Stock (NASDAQ:ABEO)
Abeona Therapeutics Stock (NASDAQ: ABEO)
Categories: All
Tuesday, April 23, 2024
- Crude Oil Moves Higher; General Motors Earnings Top ViewsAvi Kapoor - 1 day ago
- Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - 1 day ago
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - 1 day ago
- Dow Jumps Over 200 Points; US Services PMI Falls In AprilAvi Kapoor - 1 day ago
- US Stocks Higher; PepsiCo Posts Upbeat EarningsAvi Kapoor - 1 day ago
- FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares SinkVandana Singh - 1 day ago
- Cantor Fitzgerald Reiterates Overweight on Abeona Therapeutics, Maintains $36 Price TargetBenzinga Newsdesk - 1 day ago
- Market-Moving News for April 23rdBenzinga Newsdesk - 1 day ago
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - 1 day ago
- Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving PremarketAvi Kapoor - 1 day ago
- Abeona Therapeutics shares are trading lower after the company announced the FDA issued a Complete Response Letter in response to the company's Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.Benzinga Newsdesk - 1 day ago
- Calix Reports Mixed Results, Joins Cadence Design Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionAvi Kapoor - 2 days ago
Monday, April 22, 2024
- Abeona Therapeutics shares are trading lower after the company announced the FDA issued a Complete Response Letter in response to the company's Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.Benzinga Newsdesk - 2 days ago
- Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - 2 days ago
- Abeona Therapeutics Says Letter Didn't Identify Deficiencies Related To Clinical Efficacy Or Clinical Safety Data In BLABenzinga Newsdesk - 2 days ago
- Abeona Therapeutics Anticipates Completing And Submitting Requested CMC Information In Q3 2024Benzinga Newsdesk - 2 days ago
- Abeona Therapeutics Provides Regulatory Update On Pz-cel; CRL Did Not Identify Deficiencies Related To Clinical Efficacy Or Clinical Safety Data In BLA, And No New Clinical Studies Requested By FDA To Support ApprovalBenzinga Newsdesk - 2 days ago
- Trading Halt: Halted at 4:01:00 p.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - 2 days ago
Tuesday, March 19, 2024
Monday, March 18, 2024
Thursday, February 08, 2024
Wednesday, February 07, 2024
Thursday, February 01, 2024
Monday, January 08, 2024
Monday, November 27, 2023
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Nov 27, 2023, 12:30PM
- Abeona Therapeutics shares are trading higher after the company announced the FDA accepted and granted Priority Review for the Biologics License Application for pz-cel.Benzinga Newsdesk - Nov 27, 2023, 10:41AM
- Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)Benzinga Newsdesk - Nov 27, 2023, 7:32AM
Monday, November 13, 2023
Friday, September 29, 2023
Tuesday, September 26, 2023
Wednesday, August 30, 2023
Thursday, August 24, 2023
Tuesday, August 08, 2023
Wednesday, August 02, 2023
Thursday, July 13, 2023
Monday, July 03, 2023
Wednesday, May 24, 2023
Thursday, May 11, 2023
- Recap: Abeona Therapeutics Q1 EarningsBenzinga Insights - May 11, 2023, 8:45AM
- Abeona Therapeutics Q1 EPS $(0.54) Beats $(0.61) Estimate; Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $40.7M Are Sufficient Resources To Fund Operations Into Q3 Of 2024Benzinga Newsdesk - May 11, 2023, 7:47AM